Related Experiment Video
Updated: Jul 22, 2026

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Published on: July 28, 2012
Colon Cancer With Bladder Invasion: A Single Center Experience
Tzu-Wei Chiang1,2, Li-Wen Chang3,4,5, Feng-Fan Chiang1
1Division of Colorectal Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
Complete resection of colon cancer with bladder invasion offers good outcomes. Positive surgical margins and emergency operations are key risk factors impacting overall survival (OS) in these patients.
Area of Science:
- Oncology
- Surgical Oncology
- Gastrointestinal Surgery
Background:
- Colon cancer with bladder invasion presents a complex surgical challenge.
- Understanding outcomes is crucial for treatment planning and patient prognosis.
Purpose of the Study:
- To investigate the oncologic outcomes of colon cancer with bladder invasion following surgical intervention.
- To identify risk factors influencing overall survival (OS).
Main Methods:
- A retrospective analysis of 41 patients with colon cancer and bladder invasion treated between 2011 and 2022.
- Kaplan-Meier analyses and Cox proportional hazards models were used to assess risk factors for OS.
Main Results:
- Median OS varied by stage (Stage 2: 71.8 months, Stage 3: 50.8 months, Stage 4: 11.2 months).
- Patients with negative surgical margins had significantly better OS (71.8 months) compared to those with positive margins (10.5 months).
- Positive surgical margins (HR=3.64) and emergency operations (HR=4.57) were independent predictors of poorer OS.
Conclusions:
- Complete resection of colon cancer with bladder invasion can lead to favorable oncologic results.
- Balancing surgical margin status and quality of life is key in choosing between partial and radical cystectomy.
- Surgical margin involvement and emergency surgery are significant independent risk factors for overall survival.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
09:243-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
Published on: September 13, 2018